Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Day

Showing results (351-360 of 501) with videos related to

Pageof 51
Sort By:
The Journal of Rheumatology|November 17, 2015
Barriers to Care in Gout: From Prescriber to PatientStefanie Vaccher, Diluk R W Kannangara, Melissa T Baysari, et al.
Proceedings. Biological Sciences|July 10, 2015
When and how did the terrestrial mid-Permian mass extinction occur? Evidence from the tetrapod record of the Karoo Basin, South AfricaMichael O Day, Jahandar Ramezani, Samuel A Bowring, et al.
The Medical Journal of Australia|August 2, 2005
Pethidine in emergency departments: promoting evidence-based prescribingKaren I Kaye, Susan A Welch, Linda V Graudins, et al.
Applied Clinical Informatics|January 24, 2014
Audit and feedback of antibiotic use: utilising electronic prescription dataM T Baysari, K Oliver, B Egan, et al.
British Journal of Clinical Pharmacology|February 21, 2024
Estimation of adherence to urate-lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient-reported dosingMarcel Schulz, Matthew J Coleshill, Richard O Day, et al.
European Journal of Clinical Pharmacology|June 26, 2018
Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM)S S Kumar, H McManus, T Radovich, et al.
The Medical Journal of Australia|December 7, 1992
Non-steroidal anti-inflammatory drug induced upper gastrointestinal haemorrhage and bleedingR O Day, D A Henry, K D Muirden, et al.
British Journal of Clinical Pharmacology|January 20, 2023
Blood, dose recommendation reports and phone calls: Experiences of a therapeutic drug monitoring advisory service for vancomycinJane E Carland, Alexandra E Stacy, Andrea L Schaffer, et al.
British Journal of Clinical Pharmacology|July 10, 2024
Economic evaluations of therapeutic drug monitoring interventions in acute hospital-based settings: A systematic reviewJane E Carland, David J Carland, Jonathan Brett, et al.
BMJ Open|August 26, 2016
OPAL: a randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain. Trial protocolChung-Wei Christine Lin, Andrew J McLachlan, Jane Latimer, et al.
Pageof 51

Showing results (351-360 of 501) with videos related to

Sort By:
Pageof 51
The Journal of Rheumatology|November 17, 2015
Barriers to Care in Gout: From Prescriber to PatientStefanie Vaccher, Diluk R W Kannangara, Melissa T Baysari, et al.
Proceedings. Biological Sciences|July 10, 2015
When and how did the terrestrial mid-Permian mass extinction occur? Evidence from the tetrapod record of the Karoo Basin, South AfricaMichael O Day, Jahandar Ramezani, Samuel A Bowring, et al.
The Medical Journal of Australia|August 2, 2005
Pethidine in emergency departments: promoting evidence-based prescribingKaren I Kaye, Susan A Welch, Linda V Graudins, et al.
Applied Clinical Informatics|January 24, 2014
Audit and feedback of antibiotic use: utilising electronic prescription dataM T Baysari, K Oliver, B Egan, et al.
British Journal of Clinical Pharmacology|February 21, 2024
Estimation of adherence to urate-lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient-reported dosingMarcel Schulz, Matthew J Coleshill, Richard O Day, et al.
European Journal of Clinical Pharmacology|June 26, 2018
Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM)S S Kumar, H McManus, T Radovich, et al.
The Medical Journal of Australia|December 7, 1992
Non-steroidal anti-inflammatory drug induced upper gastrointestinal haemorrhage and bleedingR O Day, D A Henry, K D Muirden, et al.
British Journal of Clinical Pharmacology|January 20, 2023
Blood, dose recommendation reports and phone calls: Experiences of a therapeutic drug monitoring advisory service for vancomycinJane E Carland, Alexandra E Stacy, Andrea L Schaffer, et al.
British Journal of Clinical Pharmacology|July 10, 2024
Economic evaluations of therapeutic drug monitoring interventions in acute hospital-based settings: A systematic reviewJane E Carland, David J Carland, Jonathan Brett, et al.
BMJ Open|August 26, 2016
OPAL: a randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain. Trial protocolChung-Wei Christine Lin, Andrew J McLachlan, Jane Latimer, et al.
Pageof 51